In 5-4 ruling, Justices say generic makers are not liable for design of drugs

June 25, 2013

The Supreme Court ruled on Monday that generic drug manufacturers could not be sued by patients who claim that drugs they took were defectively designed. The decision is a significant victory for the generic drug industry, but further narrows the recourse for people who are injured by such drugs. (New York Times)